Hepatocyte transplantation: a clinical case of fatal portal thrombosis

References

[1] Dhawan A. et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 2004; 78; 12: 1812-4.

[2] Esch J.S. 2nd et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005; 23; 4: 463.

[3] Ambrosino G. et al. Isolated hepatocyte transplantation for CriglerNajjar syndrome type 1. Cell Transplant 2005; 14; 2-3: 151.

[4] Darwish A.A. et al. Permanent access to the portal system for oellular transplantation using an implantable port device. Liver Transpl 2004; 10; 9: 1213 -5.

[5] Shapiro J. et al. Islet transplantation in seven patients with type I

[6] diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-8.

[7] Raper S.E. et al. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg 1996; 223; 2: 116-26.

[8] Vulliet P.R. et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004; 363: 783-4.

[9] Bilir B.M. et al. Hepatocyte transplantation in acute liver failure. Liver Transpl 2000; 6; 1: 32-40.

[10] Fox I.J. et al. Treatment of the Crigler-Najjar syndrome type 1 withhepatocyte transplantation. N Engl J Med 1998; 338: 1422-6.

RIGHTS & PERMISSIONS

Eco-Vector